抗EGFR单克隆抗体治疗肿瘤进展
toR，BiancoR,ralph lauren danmark，eta1．Antitumoreffectandpo—tentiationofcytotoxicdr ugsactivityinhumancancercellsbyZD-1839(Iressa)，anepidermalgrowthfactorreceptorselect ivetyrosinekinaseinhibitor．ClinCancerRes，2000；6：20 53—206314RowinskyEK，SchwartzGH，GollobJA，eta1．Safet y,moncler paris，pharmacoki-netics，andactivityofABX-EGF，afullyhumananti-epidermalgrowthfactorreceptormonoclonalantibodyinp atientswithmetastaticrenalcellcancer．JClinOncol，20 04,abercrombie paris；22：3003—301515FoonKA，YangX-D，WeinerLM，eta1．Preclinicalandclinicalevaluationso fABX-EGF，afullyhumananti-epidermalgrowthfactorreceptorantibody．IntJRadiatOn colBiolPhys，2004：58：984—99016CrombetT，OsorioM，Cruz T，eta1．Useofthehumanizedanti-epi-dermalgrowthfactorreceptormonoclonalantibodyh-r3incombina-tionwithradiotherapyinthetreatmentoflocallyadvance dheadandneckcancerpatients．JClinOncol，2004：22：1646 —165417Crombet-RamosT，RakJ，PerezR，eta1．Antiproliferative，antian—g iogenicandproapoptoticactivityofh-R3：Ahumanizedanti-EGFRantibody．IntJCancer，2002；101：567—57518CrombetT ，TorresL，NeningerE，eta1．Pharmacologicalevaluationo fhumanizedanti-epidermalgrowthfactorreceptor，monoclonalanti-bodyh-r3，inpatientswithadvancedepithelial-derivedcancer．JIm—munother，2003；26：139—14819Crombe rT，FigueredoJ,moncler doudoune，eta1．Treatmentofhigh-gradeastrocytictumorswiththehumanizedanti-·EGF--Rantibodyh-R3andradiother-apy．JClinOncol，2005,burberry paris；23(16S)：255420BodeU，BuchenS，eta1．Resultsofaphase1 1trialofh-R3mono-clonalantibody(nimotuzumab)inthetreatmentofresista ntorre-lapsedhigh-gradegliomasinchildrenandadolescents．JClinOncol，20 06；24(18S)：1522